The Role of VEGFA, COX2, HUR and CUGBP2 in Predicting the Response to Neoadjuvant Therapy in Rectal Cancer Patients

Background and objectives: The effectiveness of neoadjuvant therapy, which is commonly used for stage II-III rectal cancer (RC) treatment, is limited. Genes associated with the pathogenesis of RC could determine response to this treatment. Therefore, the aim of this study was to investigate the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Pauzas, Henrikas, Gyvyte, Ugne, Latkauskas, Tadas, Kairevice, Laura, Lizdenis, Paulius, Svagzdys, Saulius, Birgiolaite, Erika, Kuliaviene, Irma, Kupcinskas, Juozas, Tamelis, Algimantas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230171/
https://www.ncbi.nlm.nih.gov/pubmed/32331433
http://dx.doi.org/10.3390/medicina56040192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230171/
https://www.ncbi.nlm.nih.gov/pubmed/32331433
http://dx.doi.org/10.3390/medicina56040192

Ejemplares similares